{
  "schemaVersion": 1,
  "id": "research-097",
  "slug": "097-why-dsip-free-form-and-acetate-need-separate-evidence-checks",
  "title": "Why DSIP Free Form and Acetate Need Separate Evidence Checks",
  "catalogLabel": "DSIP",
  "productCollection": "https://heritagebiolabs.com/research-library/products/dsip",
  "productHandles": [
    "dsip-433"
  ],
  "productUrls": [
    "https://heritagebiolabs.com/product/dsip-433"
  ],
  "readingFocus": "Interpreting evidence",
  "readingFocusNote": "Reading focus is a navigational tag, not an evidence grade.",
  "wordCount": 296,
  "sourceYears": [
    2026
  ],
  "paragraphs": [
    "A peptide is a short chain connected by bonds between amino acids. The sequence defines the chain, while a preparation may include an accompanying ion, water or other material. Delta sleep-inducing peptide, or DSIP, illustrates why both levels of description are useful. The FDA's July 2026 briefing considered emideltide in its free form and emideltide acetate as distinct bulk substances. An acetate salt can contain the same underlying chain, but it is a different description of the material weighed, characterized and compared. [1]",
    "The FDA reviewed nomination documents and certificates of analysis. It found ambiguity over which form the nominators intended. It also found that some identifying details in the paperwork did not consistently describe the same form. This is a problem for interpreting published experiments: a paper that only says DSIP may not let a reader determine which chemical preparation was studied. The same issue arises when a paper does not identify the preparation with enough detail to reproduce the work. [1]",
    "That uncertainty has practical consequences for research. A comparison of two preparations might measure the amount of active peptide, which can differ from the gross weight of the material. Chemical identity alone also does not establish that batches have the same purity or that the peptide is stable in the same setting. A result from one preparation should be attributed to that material unless there is a sound reason to treat the comparison material as equivalent. [1]",
    "The 2026 review was prepared for an advisory discussion about eligibility for use in pharmacy compounding. A briefing or committee discussion is a different kind of evidence from a controlled clinical trial. It does not establish that a DSIP product improves sleep, is interchangeable with another product or is FDA approved for the proposed use. [1]"
  ],
  "sources": [
    {
      "number": 1,
      "citation": "US Food and Drug Administration. FDA Briefing Document for Emideltide-Related Bulk Drug Substances. Pharmacy Compounding Advisory Committee (2026-07-23).",
      "url": "https://www.fda.gov/media/193344/download"
    }
  ],
  "canonicalUrl": "https://heritagebiolabs.com/research-library/articles/097-why-dsip-free-form-and-acetate-need-separate-evidence-checks",
  "markdownUrl": "https://heritagebiolabs.com/research-library/data/articles/097-why-dsip-free-form-and-acetate-need-separate-evidence-checks.md",
  "jsonUrl": "https://heritagebiolabs.com/research-library/data/articles/097-why-dsip-free-form-and-acetate-need-separate-evidence-checks.json",
  "provenance": {
    "sourceArchive": "Peptide Research Articles - All 82 Volumes.zip",
    "sourceArchiveSha256": "9796bec477cbe2f8017dda81c7e58260985a13bdda1f934e8eb8d0549c2cada5",
    "sourceVolume": "Peptide Research Articles 020 - DSIP and Epitalon.docx",
    "sourceArticleNumber": 97,
    "contentSha256": "9e12ab993bfc4904cce37f4c18b03017c660b3ef8f890003e4695483b9e24386",
    "statement": "Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed."
  },
  "scope": "Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend."
}
